Jan. 15, 2021: State Advocacy Update
Now on demand: National roadmap on state-level efforts to end the nation's drug overdose epidemic in the latest State Advocacy Update.
AMA statement on HHS decision to remove barriers for opioid treatment
AMA strongly endorses today’s decision by HHS to allow physicians to prescribe without a waiver highly effective medication for opioid use disorder.
Jan. 8, 2021: Advocacy Update spotlight on what’s ahead for AMA advocacy this year
What’s ahead for AMA advocacy this year in this week's Advocacy Update spotlight.
Jan. 8, 2021: State Advocacy Update
Coverage for all forms of MOUD now required by Medicaid and more in the latest State Advocacy Update.
Pandemic tops advocacy agenda, but isn’t the only item of business
A new year with new governors, state legislators and regulators, is a chance to recalibrate health care priorities but some 2020 issues still need advocacy.
Collaborative care model for mental health, addiction treatment
The physician architects of a Penn Medicine model of integrated physical and mental health care detail its success.
Policy road map shows the way to end the overdose epidemic
It’s been clear for years that, to end the drug overdose epidemic, health insurance company and pharmacy benefit managers’ barriers to evidence-based treatment and non-opioid pain management must be eliminated.
Membership Moves Medicine™
- Free access to JAMA Network™ and CME
- Save hundreds on insurance
- Fight for physicians and patient rights